Marcoli M, Ricevuti G, Mazzone A, Bekkering M, Lecchini S, Frigo G M
Department of Internal Medicine and Therapeutics, University of Pavia, Italy.
Int J Immunopharmacol. 1988;10(4):425-33. doi: 10.1016/0192-0561(88)90129-4.
Inhibition of human granulocyte chemotaxis towards casein was observed in the presence of both the mu and kappa opioid receptor agonists, which, per se, exhibited chemokinetic activity. Naloxone was found to prevent both the opioid-related and opioid-unrelated increase in granulocyte migration. Moreover, morphine inhibited the aggregation response of granulocytes in a naloxone-sensitive way, while the opioid peptides were ineffective. Although opioid agonists with different receptor specificity were capable of strongly modifying human granulocyte migration, no conclusion can be drawn on the role of opioid receptors in regulating migrating activity. On the other hand, opioid receptor activation by morphine is likely to be responsible for aggregation inhibition.
